Labcyte® Acoustic Platform Essential to Identification of Novel Cancer Drug Candidates
SUNNYVALE, Calif.–(BUSINESS WIRE)–Labcyte technology helps pharmaceutical companies identify new drug candidates
Read more on Business Wire
For the Treatment of Ovarian Cancer, Pegylated Liposomal Doxorubicin/Carboplatin Will Replace Paclitaxel/Carboplatin …
Decision Resources, one of the world’s leading research and advisory firms for pharmaceutical and healthcare issues, finds that although platinum-based treatment will continue to be the standard of care for first- and second-line treatment of platinum-sensitive ovarian cancer, pegylated liposomal doxorubicin /carboplatin will replace paclitaxel/carboplatin as the standard second-line treatment …
Read more on PR Newswire via Yahoo! Finance
Myrexis presents data on MPC-9528 cancer metabolism inhibitor at EORTC/NCI/AACR Symposium
Myrexis, Inc., a biotechnology company focused on discovering, developing, and commercializing novel treatments for cancer, today presented two posters at the 22nd European Organisation for Research and Treatment of Cancer (EORTC), National Cancer Institute (NCI) and American Association for Cancer Research (AACR) Symposium on “Molecular Targets and Cancer Therapeutics,” in Berlin, Germany.
Read more on News-Medical-Net
Access Pharmaceuticals ProLindac™ And CobaCyte™ Oncology Research Displayed At The Innovations In Cancer Prevention …
ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced that two oncology posters are being displayed this week at the Innovations in Cancer Prevention and Research Conference at the Austin Convention Center in Austin, TX. The …
Read more on Medical News Today
VIB – Flanders Institute for Biotechnology – is a nonprofit research institute conducting pioneering research in the life sciences. More than 1000 scientists explore the molecular mechanisms responsible for the functioning of the human body, plants and micro-organisms. VIB strives to apply the inventions with commercial value for the benefit of consumers and patients. This DVD features three examples of VIB research: cancer, Crohn’s disease and ALS. Copyright www.vib.be
VIB – Flanders Institute for Biotechnology – is a nonprofit research institute conducting pioneering research in the life sciences. More than 1000 scientists explore the molecular mechanisms responsible for the functioning of the human body, plants and micro-organisms. VIB strives to apply the inventions with commercial value for the benefit of consumers and patients. This animation features images of VIB research in the field of cancer. Copyright www.vib.be
EDP Biotech receives $244,000 grant under QTDP program for colon cancer blood test
EDP Biotech Corporation was awarded a $244,000 grant from the federal government under the Qualifying Therapeutic Discovery Project program as a result of the company’s work in the development of their ColoMarker test, an early detection blood test for colon cancer.
Read more on News-Medical-Net
Maven Semantic: Cancer Stem Cell Research Database
Maven Semantic announces updates to their Cancer Stem Cell research database.
Read more on Business Wire via Yahoo! Finance
Oncolytics Biotech® Inc. Collaborators Present Data from U.K. Translational Colorectal Cancer Study at the …
Oncolytics Biotech Inc.
Read more on PR Newswire via Yahoo! Finance
NIH awards Phase I SBIR grant to develop Generic Antibodies for cancer
Rockland Immunochemicals Inc., a biotechnology company focusing on antibodies and antibody based tools for basic research, diagnostic assay development and preclinical studies, today announced that it has received a Phase I Small Business Innovation Research (SBIR) grant from the National Institutes of Health to develop Generic Antibodies “Biosimilars” for the Treatment of Cancer.
Read more on News-Medical-Net
Powered by Yahoo! Answers
